A
$ Value
$0
Shares
60,000
Price
$0
Filed
Feb 17
Insider
Name
Friedl-Naderer Johanna
Title
Chief Commercial Officer
CIK
0001915598
Roles
Officer
Transaction Details
Transaction Date
2026-02-12
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
154,729
Footnotes
Consists of shares of Common Stock issuable under 60,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal quarterly installments over four years with the first installment vesting on May 12, 2026. | Includes 132,152 unvested RSUs. | This option was granted on February 12, 2026. The shares underlying the option are scheduled to vest over four years in equal monthly installments through February 12, 2030.
Filing Info
Friedl-Naderer Johanna's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-05 | DYN | ▼ | $2K |
| 2026-02-12 | DYN | A | $0 |
| 2026-02-12 | DYN | A | $0 |
| 2025-12-05 | DYN | ▼ | $3K |
| 2025-09-05 | DYN | ▼ | $2K |
| 2025-09-04 | DYN | ▼ | $12K |
| 2025-07-16 | DYN | A | $0 |
| 2025-06-05 | DYN | ▼ | $2K |
Other Insiders at DYN (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Posner Brian S | $118K | — | 2026-03-30 |
|
Cox John
CEO & President
|
— | $41K | 2026-03-05 |
| Rhodes Jason P | — | $16.5M | 2026-04-22 |
|
Lucera Erick
Chief Financial Officer
|
— | $107K | 2026-04-01 |
|
Kerr Douglas
Chief Medical Officer
|
— | $13K | 2026-03-05 |
| Kersten Dirk | — | $24.7M | 2026-04-22 |
|
Friedl-Naderer Johanna
Chief Commercial Officer
|
— | $2K | 2026-03-05 |